MELISSA LARSEN: Open Payments
NPI 1992103386 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 11 payments from 7 companies in 2025. Trend: 2023 $738 · 2024 $705 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $244 |
| Janssen Pharmaceuticals, Inc | 1 | $150 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Lundbeck LLC | 2 | $96 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| ABBVIE INC. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: REXULTI, SPRAVATO, ARISTADA, LYBALVI, COBENFY, VRAYLAR, ENTYVIO.
Industry payments across IA — which companies pay providers there.
